Skip to main content

Department of Biostatistics Archives

Specialty pharmacists help reduce MS relapse risk

Jul. 28, 2022—Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.

Read more


Epidemiology PhD program receives CEPH accreditation

Jul. 21, 2022—The Vanderbilt Epidemiology PhD Program has received accreditation from the Council on Education for Public Health (CEPH).

Read more


Davidson named to receive the Geoffrey David Chazen Faculty Award for Innovation in Medical Education

Jun. 30, 2022—The Academy for Excellence in Education is pleased to announce Mario Davidson, PhD, is the recipient of the 2022 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.

Read more


Grant to help train biostatisticians in West Africa

Jun. 16, 2022—Vanderbilt and Aminu Kano Teaching Hospital have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa.

Read more


Capacity-building grant trains biostatisticians in West Africa

Jun. 8, 2022—The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa. 

Read more


Sex & race & door-to-ECG time

Jun. 2, 2022—More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.

Read more


VUMC’s Pietenpol, Shyr named AACR Fellows

Mar. 22, 2022—Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

Read more


Impact of digital health interventions

Jan. 31, 2022—Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.

Read more


Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

Jan. 14, 2022—A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.

Read more


VUMC team puts tool to reduce heart failure admissions to test

Nov. 11, 2021—Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

Read more


VUMC tests drugs for COVID outpatient treatment

Nov. 11, 2021—  by Paul Govern Vanderbilt University Medical Center has joined a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a...

Read more


Raman, Balucan receive health equity research grants

Sep. 9, 2021—Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more